Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -96.72% | -- | -52.40% | 166,000.00% | 790.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -96.72% | -- | -52.40% | 166,000.00% | 790.94% |
| Cost of Revenue | -78.99% | -- | -47.10% | 426.44% | 360.65% |
| Gross Profit | -99.78% | -- | -53.26% | 2,463.95% | 963.73% |
| SG&A Expenses | 11.37% | 22.61% | -20.81% | -13.90% | -96.16% |
| Depreciation & Amortization | -- | -- | -10.66% | -51.85% | -92.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.92% | -15.77% | -18.84% | -0.63% | -92.24% |
| Operating Income | -121.04% | -180.59% | -82.59% | 125.50% | 119.33% |
| Income Before Tax | -121.32% | -200.46% | 26.24% | 107.25% | 108.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -121.32% | -200.46% | 26.24% | 107.25% | 108.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -121.32% | -200.46% | 23.97% | 107.17% | 108.31% |
| EBIT | -121.04% | -180.59% | -82.59% | 125.50% | 119.33% |
| EBITDA | -119.48% | -174.21% | -185.63% | 126.75% | 120.71% |
| EPS Basic | -108.64% | -105.37% | 94.76% | 100.32% | 100.88% |
| Normalized Basic EPS | -111.01% | -105.72% | 91.78% | 100.82% | 101.71% |
| EPS Diluted | -112.84% | -106.64% | 94.76% | 100.23% | 100.59% |
| Normalized Diluted EPS | -119.35% | -105.72% | 91.78% | 100.62% | 100.97% |
| Average Basic Shares Outstanding | 145.97% | 1,767.41% | 1,349.13% | 2,129.75% | 842.34% |
| Average Diluted Shares Outstanding | 39.89% | 1,767.41% | 1,349.13% | 3,033.20% | 1,556.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
